Tactical Emergency Casualty Care TECC: Guidelines for BLS/ALS Medical Provider Response to Chemical Warfare Agents/Events CURRENT AS OF 15 JULY 2021 PREAMBLE

Dec 18, 22
Tactical Emergency Casualty Care TECC: Guidelines for BLS/ALS Medical Provider Response to Chemical Warfare Agents/Events CURRENT AS OF 15 JULY 2021 PREAMBLE



Tactical Emergency Casualty Care TECC: Guidelines for BLS/ALS Medical Provider Response to Chemical Warfare Agents/Events CURRENT AS OF 15 JULY 2021 PREAMBLE

ESP 

El Comité de Directrices de C-TECC ha publicado el anexo CBRN de TECC titulado Directrices de atención táctica de emergencia para víctimas (TECC) para proveedores médicos de BLS / ALS: respuesta a agentes / eventos de guerra química. Este anexo sirve para ampliar las pautas de TECC al abordar el tratamiento requerido para los pacientes durante un evento CBRN. Este documento, que se centra principalmente en las enfermedades y lesiones sufridas por el uso de agentes químicos, tiene como objetivo brindar orientación a los proveedores médicos que brindan tratamiento durante las tres fases de la atención. Además, se proporcionan recomendaciones de orientación y tratamiento para pacientes expuestos a agentes de base farmacéutica "Pharmaceutical Based Agents" (PBA's), que han sido identificados por expertos civiles y antiterroristas como una amenaza. Las grandes cantidades y el aumento de la disponibilidad de opiáceos sintéticos plantean un riesgo significativo de liberación deliberada durante actos dinámicos de violencia.


Acceda al documento de Pautas a continuación.


ENG

The C-TECC Guidelines Committee has published the TECC CBRN Annex titled Tactical Emergency Casualty Care (TECC) Guidelines for BLS/ALS Medical Provider: Response to Chemical Warfare Agents/Events. This annex serves to augment the TECC guidelines by addressing treatment required to patients during a CBRN event. Primarily focused on illness and injury sustained through the use of chemical agents, this document aims to provide guidance to medical providers rendering treatment during the three phases of care. Additionally, guidance and treatment recommendations are provided for patients exposed to Pharmaceutical Based Agents (PBA's), having been identified by civilian and counter-terrorism experts as a threat. The large quantities and rise in availability of synthetic opiates pose a significant risk of deliberate release during dynamic acts of violence.


Please access the Guidelines document below.


DESCARGAR pdf / DOWNLOAD pdf  ENG

Leave a Comment

Like articles like this one?

Join our Email List and get the latest TCCC/TECC/TEMS news bulletins, articles, product releases, and more!

Free Delivery

On all orders over $99 within CONUS and to APO/FPO

Easy Returns

We're here to help! Satisfaction Guaranteed

Knowledgeable Staff

Ready to assist you at a moment's notice

Safe& Secure Checkout

World’s most advanced and secure website encryption.